Genetic Variation as a Modifier of Association Between Therapeutic Exposure and Subsequent Malignant Neoplasms in Cancer Survivors

Cancer - United States
doi 10.1002/cncr.29096
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Subsequent Neoplasms of the CNS Among Survivors of Childhood Cancer: A Systematic Review

The Lancet Oncology
Oncology
2013English

Genetic Variation in POT1 and Risk of Thyroid Subsequent Malignant Neoplasm: A Report From the Childhood Cancer Survivor Study

PLoS ONE
Multidisciplinary
2020English

Genetic Effect of Chemotherapy Exposure in Children of Testicular Cancer Survivors

Clinical Cancer Research
Cancer ResearchOncology
2015English

Subsequent Malignant Neoplasms in Pediatric Patients Initially Diagnosed With Neuroblastoma

Journal of Pediatric Hematology/Oncology
Child HealthOncologyPediatricsHematologyPerinatology
2015English

αB-crystallin: Portrait of a Malignant Chaperone as a Cancer Therapeutic Target

Pharmacology and Therapeutics
Pharmacology
2016English

Therapeutic Work as a Facilitator for Return to Paid Work in Cancer Survivors

Journal of Occupational Rehabilitation
Occupational TherapyRehabilitation
2016English

Combined Risk of Second Malignant Neoplasms and Cardiovascular Disease in Long-Term Hodgkin Lymphoma Survivors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

New Strategies in Myeloproliferative Neoplasms: The Evolving Genetic and Therapeutic Landscape

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy